Expanding sales of mask-making machines and the medical business
First written in FY2020. 2 of 4 entries say "Advanced", first in FY2021-Q1. Latest entry: 2026-04-03.
Zuiko moved to the "Worse" side of this theme in 2026.
The whole theme swung hardest in 2022: 1 of 9 companies on the "Worse" side.
0 other companies' latest entry also says "Worsened".
- 2026-04-03WorsenedRevision of earnings forecasts
「The mask-making machine had been recorded under machinery and equipment and tools, furniture and fixtures. However, as profitability declined and recovery of the investment was no longer expected, its carrying amount was written down to its recoverable amount, and the decrease was recorded as an impairment loss.」
The company recorded an impairment loss of ¥95.152 million on the mask-making machine after profitability declined and recovery of the investment was no longer expected. - FY2021AdvancedAnnual report
「In addition, the Group has responded flexibly to changes in the business environment, including the successful development of mask-making machines as a new business, the start of machine sales, and the start of mask product sales through a consolidated subsidiary.」
It describes specific progress regarding mask-making machines, including successful product development, the start of machine sales, and the start of mask product sales through a consolidated subsidiary. - FY2021-Q1AdvancedAnnual report
「In response to growing demand for masks, the Group newly began manufacturing and selling mask-making machines and achieved a certain level of success.」
It states that, in response to growing demand for masks, the Group began manufacturing and selling mask-making machines and achieved a certain level of success. - FY2020First statedAnnual report
「We will seek to secure profits by expanding domestic and overseas sales of mask-making machines, increasing sales in the medical business, anticipating a rebound in the post-COVID market, expanding orders in global markets and building a structure to improve productivity across the Group.」
The filing identifies expanded domestic and overseas sales of mask-making machines, increased sales in the medical business, global order expansion and a Group-wide productivity structure as responses and opportunities related to COVID-19.